Scott Andrew Jordan
Director/Miembro de la Junta en Stingray Therapeutics, Inc. .
Perfil
Scott Andrew Jordan is the founder of Healthiosxchange, which was founded in 2013.
He is currently a Director at Stingray Therapeutics, Inc. Mr. Jordan's former positions include Chief Financial Officer at Iterion Therapeutics, Inc. from 2016 to 2018, Vice President at Healthios Capital Markets LLC from 2010 to 2013, Chief Financial Officer at Salarius Pharmaceuticals LLC, and Chief Business Officer at Salarius Pharmaceuticals, Inc. from 2019 to 2020.
Mr. Jordan's education includes an undergraduate degree from Michigan State University and an MBA from Kellstadt Graduate School of Business.
Cargos activos de Scott Andrew Jordan
| Empresas | Cargo | Inicio |
|---|---|---|
Stingray Therapeutics, Inc.
 Stingray Therapeutics, Inc. BiotechnologyHealth Technology Stingray Therapeutics, Inc. specializes in identifying targets with untapped potential to modulate the tumor microenvironment. The company was founded by Jonathan P. Northrup and Sunil Sharma and is headquartered in Houston, TX. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Scott Andrew Jordan.
| Empresas | Cargo | Fin |
|---|---|---|
| SALARIUS PHARMACEUTICALS, INC. | Director Financiero/CFO | 13/09/2019 |
Iterion Therapeutics, Inc.
 Iterion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Iterion Therapeutics, Inc. provides pharmaceuticals services. The firm products are used in the treatment of colorectal, hematopoietic, and other targeted cancers. The company was founded by Jonathan P. Northrup in 2010 and is headquartered in Houston, TX. | Director Financiero/CFO | 01/08/2018 |
| Healthiosxchange | Fundador | 01/06/2016 |
Healthios Capital Markets LLC
 Healthios Capital Markets LLC Investment ManagersFinance Healthios Capital Markets LLC provides financial advisory services. The private company is based in Northbrook, IL and has subsidiaries in Thailand and Singapore. The company was founded by Fritz Reichenbach. | Corporate Officer/Principal | 01/03/2013 |
Salarius Pharmaceuticals LLC
 Salarius Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Salarius Pharmaceuticals LLC manufactures drugs for cancer. It specializes in epigenetics, pipeline and LSD1 research, and development services. The company was founded by Jonathan P. Northrup and Sharma Sunil in 2014 and is headquartered in Houston, TX. | Director Financiero/CFO | - |
Formación de Scott Andrew Jordan.
| Michigan State University | Undergraduate Degree |
| Kellstadt Graduate School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SALARIUS PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
Iterion Therapeutics, Inc.
Iterion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Iterion Therapeutics, Inc. provides pharmaceuticals services. The firm products are used in the treatment of colorectal, hematopoietic, and other targeted cancers. The company was founded by Jonathan P. Northrup in 2010 and is headquartered in Houston, TX. | Health Technology |
Healthios Capital Markets LLC
Healthios Capital Markets LLC Investment ManagersFinance Healthios Capital Markets LLC provides financial advisory services. The private company is based in Northbrook, IL and has subsidiaries in Thailand and Singapore. The company was founded by Fritz Reichenbach. | Finance |
Salarius Pharmaceuticals LLC
Salarius Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Salarius Pharmaceuticals LLC manufactures drugs for cancer. It specializes in epigenetics, pipeline and LSD1 research, and development services. The company was founded by Jonathan P. Northrup and Sharma Sunil in 2014 and is headquartered in Houston, TX. | Health Technology |
Stingray Therapeutics, Inc.
Stingray Therapeutics, Inc. BiotechnologyHealth Technology Stingray Therapeutics, Inc. specializes in identifying targets with untapped potential to modulate the tumor microenvironment. The company was founded by Jonathan P. Northrup and Sunil Sharma and is headquartered in Houston, TX. | Health Technology |
| Healthiosxchange |
- Bolsa de valores
- Insiders
- Scott Andrew Jordan
